BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24474236)

  • 1. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma.
    Anayannis NV; Schlecht NF; Ben-Dayan M; Smith RV; Belbin TJ; Ow TJ; Blakaj DM; Burk RD; Leonard SM; Woodman CB; Parish JL; Prystowsky MB
    PLoS One; 2018; 13(2):e0191581. PubMed ID: 29451891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
    Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
    Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N
    Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck.
    Jacobi C; Ayx I; Fritsche K; Piontek G; Hoffmann D; Weirich G; Knopf A
    Oncotarget; 2015 Feb; 6(5):3462-70. PubMed ID: 25739121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
    Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER
    Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management.
    Tran NH; Sais D; Tran N
    J Med Virol; 2024 Jun; 96(6):e29746. PubMed ID: 38884391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents.
    D'Souza G; Anantharaman D; Gheit T; Abedi-Ardekani B; Beachler DC; Conway DI; Olshan AF; Wunsch-Filho V; Toporcov TN; Ahrens W; Wisniewski K; Merletti F; Boccia S; Tajara EH; Zevallos JP; Levi JE; Weissler MC; Wright S; Scelo G; Mazul AL; Tommasino M; Cadoni G; Brennan P
    Oral Oncol; 2016 Nov; 62():20-27. PubMed ID: 27865368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.
    Kreimer AR; Ferreiro-Iglesias A; Nygard M; Bender N; Schroeder L; Hildesheim A; Robbins HA; Pawlita M; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Smoller SW; Ness-Jensen E; Hveem K; D'Souza G; Visvanathan K; May B; Ursin G; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Brenner N; Hoffman-Bolton J; Kaaks R; Barricarte A; Tjønneland A; Sacerdote C; Trichopoulou A; Vermeulen RCH; Huang WY; Freedman ND; Brennan P; Waterboer T; Johansson M
    Ann Oncol; 2019 Aug; 30(8):1335-1343. PubMed ID: 31185496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines.
    Albano PM; Holzinger D; Salvador C; Orosa J; Racelis S; Leaño M; Sanchez D; Angeles LM; Halec G; Schmitt M; Ramos JD; Pawlita M
    PLoS One; 2017; 12(2):e0172240. PubMed ID: 28199413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study.
    Barlow J; Gilja S; Ferrandino RM; Berger MH; Posner MR; Bakst RL; Khan MN; Teng MS; Genden EM; Chai RL; Roof SA
    Am J Otolaryngol; 2024; 45(3):104243. PubMed ID: 38442460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
    Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.
    Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR
    Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
    Strati K; Pitot HC; Lambert PF
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
    Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.
    Ambatipudi S; Langdon R; Richmond RC; Suderman M; Koestler DC; Kelsey KT; Kazmi N; Penfold C; Ho KM; McArdle W; Ring SM; Pring M; Waterboer T; Pawlita M; Gaunt TR; Davey Smith G; Thomas S; Ness AR; Relton CL
    Oral Oncol; 2018 Oct; 85():87-94. PubMed ID: 30220325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).
    Dayyani F; Etzel CJ; Liu M; Ho CH; Lippman SM; Tsao AS
    Head Neck Oncol; 2010 Jun; 2():15. PubMed ID: 20587061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).
    Chandra J; Woo WP; Finlayson N; Liu HY; McGrath M; Ladwa R; Brauer M; Xu Y; Hanson S; Panizza B; Frazer IH; Porceddu SV
    Cancer Immunol Immunother; 2021 Mar; 70(3):743-753. PubMed ID: 32918586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods.
    Li D; Thomas C; Shrivastava N; Gersten A; Gadsden N; Schlecht N; Kawachi N; Schiff BA; Smith RV; Rosenblatt G; Augustine S; Gavathiotis E; Burk R; Prystowsky MB; Guha C; Mehta V; Ow TJ
    J Med Virol; 2023 Feb; 95(2):e28388. PubMed ID: 36477880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen XJ; Sun K; Jiang WW
    Virol J; 2016 May; 13():81. PubMed ID: 27206495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.